Reported about 7 hours ago
Celltrion Inc. announced in a regulatory filing that its U.S. subsidiary has purchased Imclone Systems LLC from Eli Lilly for $330 million. The deal is expected to be finalized by the end of the year, facilitating upgrades to the facility that will help protect key products from U.S. tariffs.
Source: YAHOO